arrow
R

Rosalind A. Eeles

royal marsden nhs foundation trust
H指数:136
被引数:8.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The molecular heterogeneity and clinical impact of genomic driver alterations in prostate cancer

前列腺癌中基因组驱动突变的分子异质性与临床影响

2026-10-160
OAAI
Recurrent mechanisms of biallelic epigenetic inactivation reveal new putative tumour suppressor genes in prostate cancer

前列腺癌中双等位基因表观遗传失活的复发机制揭示了新的潜在肿瘤抑制基因

2026-09-090
OAAI
Integrated signatures define mutational processes in prostate cancer

整合特征定义前列腺癌中的突变过程

Nature
IF48.5
2026-09-090
OAAI
Genome-wide methylome profiling of cell-free DNA enables prognostication of patients with castration-resistant prostate cancer

细胞游离DNA全基因组甲基化谱分析有助于预测去势抵抗性前列腺癌患者的预后

2026-04-100
OAAI
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study

基因组风险模型在临床护理中实施精准前列腺癌筛查的进展研究

2026-01-260
PRE
Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry

致病性变异揭示非洲血统男性前列腺癌遗传检测的候选基因

2025-10-020
OAAI
The landscape of microbial associations in human cancer
2025-01-010
PRE
The STAMPEDE2 niraparib-abiraterone acetate plus prednisolone trial: A phase III, randomised, open-label trial in patients with metastatic prostate cancer (mPC) with a deleterious alteration in a homologous recombination repair (HRR) gene starting androgen deprivation therapy (ADT)

STAMPEDE2尼拉帕利-阿比特龙醋酸盐联合泼尼松试验:一项在携带同源重组修复(HRR)基因有害变异、开始雄激素剥夺疗法(ADT)的转移性前列腺癌(mPC)患者中进行的III期、随机、开放标签试验

2024-09-010
PRE
Cluster effect for SNP-SNP interaction pairs for predicting complex traits

预测复杂性状的snp-snp相互作用对的聚类效应

2024-08-120
OAAI
The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers

前列腺癌筛查对BRCA1和BRCA2携带者的社会心理影响

2024-06-051
OAAI
Identification of Genes with Rare Loss of Function Variants Associated with Aggressive Prostate Cancer and Survival

鉴定与侵袭性前列腺癌和生存相关的罕见功能缺失变异的基因

2024-04-010
OAAI
Genomic evolution shapes prostate cancer disease type

基因组进化塑造前列腺癌疾病类型

2024-03-010
OAAI